[en] Aim
To explore the occurrence and the distribution of glucose excursions > 7.8 mmol/l by continuous glucose monitoring
(CGM) in non-diabetic patients admitted with acute coronary syndrome (ACS).
Methods
Twenty-one non-diabetic patients without baseline hyperglycaemia admitted for ACS wore a continuous
glucose monitoring system (CGMS) for a median period of 45.6 h. Occurrence and 24-h distribution of time spent with
blood glucose > 7.8 mmol/l (TS > 7.8) were retrospectively investigated.
Results
CGMS data disclosed time spent > 7.8 in 17 patients, whereas only seven of them showed at least one capillary
blood glucose test value above the threshold for the same time period. Glucose excursions were detectable earlier from
CGMS data. Hyperglycaemia was detected most frequently in the morning, more than 2 h after breakfast.
Conclusions
CGM discloses early and frequent hyperglycaemia in non-diabetic patients with ACS. Intensive glucose
monitoring during the morning time period is the most efficient in screening for hyperglycaemia and could be a valuable
guide to initiating insulin therapy and to further investigate outcomes in ACS.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
RADERMECKER, Régis ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Sultan, A.
Piot, C.
Saint-Remy, Annie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie
Avignon, A.
Renard, E.
Language :
English
Title :
Continuous glucose monitoring as a tool to identify hyperglycaemia in non-diabetic patients with acute coronary syndromes
Publication date :
2009
Journal title :
Diabetic Medicine: A Journal of the British Diabetic Association
Conaway DG, O'Keefe JH, Reid KJ, Spertus J. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol 2005 96 : 363 365.
Kadri Z, Danchin N, Vaur L, Cottin Y, Gueret P, Zeller M et al. Major impact of admission glycaemia on 30-day and 1-year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 2006 92 : 910 915.
Aronson D, Hammerman H, Kapeliovich MR, Suleiman A, Agmon Y, Beyar R et al. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care 2007 30 : 960 966.
Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006 27 : 1289 1297.
Inzucchi SE. Management of hyperglycaemia in the hospital setting. N Engl J Med 2006 355 : 1903 1911.
Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA et al. Experience with the continuous glucose monitoring system in medical intensive care unit. Diabetes Technol Ther 2004 6 : 339 347.
De Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care 2006 29 : 1750 1756.